IL17A, interleukin 17A, 3605

N. diseases: 1074; N. variants: 19
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0003615
Disease: Appendicitis
Appendicitis
0.010 GeneticVariation disease BEFREE Associations with appendicitis were found for SNPs IL-13 rs1800925 with odds ratio (OR) 6.02 (95% CI 1.52-23.78) for T/T versus C/C + T/T, for IL-17 rs2275913 with OR 2.38 (CI 1.24-4.57) for A/A vs G/G + GA, for CCL22 rs223888 with OR 0.12 (0.02-0.90), and for A/A vs G/G + GA. Signs of effect modification of age for the association with appendicitis were found for IL-13 rs1800925 and CTLA4 rs3087243. 31845023 2020
CUI: C0003869
Disease: Arthritis, Infectious
Arthritis, Infectious
0.010 Biomarker group BEFREE Impact of simultaneous neutralization of IL-17A and treatment with recombinant IL-2 on Th17-Treg cell population in S.aureus induced septic arthritis. 31790794 2020
CUI: C0011265
Disease: Presenile dementia
Presenile dementia
0.010 Biomarker disease BEFREE Serum samples from 242 memory clinic patients with an aMCI (n=88) or AD dementia (n=154) were analyzed for C-reactive protein and for 14 other inflammatory markers [interleukin (IL)-1β, interleukin-1 receptor antagonist, IL-6, IL-10, IL-12p40, IL-17a, IL-18, IL-22, IL-33, tumor necrosis factor, cluster of differentiation 40 ligand, interferon-γ, chemokine ligand (CCL) 2, and CCL4] by bead-based multiplex immunoassay. 31414991 2020
CUI: C0011644
Disease: Scleroderma
Scleroderma
0.010 Biomarker disease BEFREE Keratinocyte-conditioned media of resting, IL-17A-, and/or transforming growth factor-β-primed primary keratinocytes were used to stimulate healthy donors and scleroderma fibroblasts. 31276679 2020
CUI: C0017677
Disease: Glossitis, Benign Migratory
Glossitis, Benign Migratory
0.010 Biomarker disease BEFREE Immunopositivity for the antibodies anti-IL6, anti-IL17, and anti-IL23 revealed cytoplasmic staining, mainly basal and parabasal, in both psoriasis and geographic tongue. 31789253 2020
CUI: C0020179
Disease: Huntington Disease
Huntington Disease
0.010 Biomarker disease BEFREE In CSF of HTT gene expansion carriers, we found increased levels of proinflammatory cytokines, including IL-17, and increased consumption of the lymphocyte growth factor IL-7 before motor onset of HD. 31725947 2020
CUI: C0023645
Disease: Lichen planus follicularis
Lichen planus follicularis
0.010 Biomarker disease BEFREE The number of IL-17A-positive mast cells was significantly higher in the LPP lesions than in normal scalp. 30379356 2020
CUI: C0086873
Disease: Pseudopelade
Pseudopelade
0.010 Biomarker disease BEFREE IL-17-positive mast cell infiltration in the lesional skin of lichen planopilaris: Possible role of mast cells in inducing inflammation and dermal fibrosis in cicatricial alopecia. 30379356 2020
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.010 Biomarker disease BEFREE These data indicated that the NF-κB and MAPK pathways are involved in the repair of barrier integrity mediated by IL-17A and IL-17F, and IL-17 pathways are potential targets for gut barrier restoration therapies during HIV/AIDS. 30951887 2020
CUI: C0497327
Disease: Dementia
Dementia
0.010 Biomarker disease BEFREE Serum samples from 242 memory clinic patients with an aMCI (n=88) or AD dementia (n=154) were analyzed for C-reactive protein and for 14 other inflammatory markers [interleukin (IL)-1β, interleukin-1 receptor antagonist, IL-6, IL-10, IL-12p40, IL-17a, IL-18, IL-22, IL-33, tumor necrosis factor, cluster of differentiation 40 ligand, interferon-γ, chemokine ligand (CCL) 2, and CCL4] by bead-based multiplex immunoassay. 31414991 2020
CUI: C0729518
Disease: Bacterial respiratory infection
Bacterial respiratory infection
0.010 Biomarker group BEFREE Recent studies show that Interleukin-17 (IL-17) family cytokines are directly involved in host immune responses against respiratory bacterial infection and in particular, IL-17C is highly induced in bacterial infected respiratory epithelium. 31318581 2020
CUI: C0948908
Disease: Nephrotoxic serum nephritis
Nephrotoxic serum nephritis
0.010 AlteredExpression disease BEFREE PD1<sup>+</sup>CD4<sup>+</sup> T cell numbers and mRNA levels of IL-17A are elevated in NTN kidneys of TNF TKO mice, suggesting that augmented local Th17 responses in the TNF TKO kidney may exaggerate renal injury and fibrosis. 31736350 2020
CUI: C1449853
Disease: Papulopustular Rosacea
Papulopustular Rosacea
0.010 Biomarker disease BEFREE We hypothesize that IL-17 inhibitors, currently used successfully in psoriasis and psoriatic arthritis, could perhaps be used to treat severe and treatment-resistant papulopustular rosacea in the future; however, clinical trials and case reports will be needed to dictate expanded indications of IL-17 inhibitors. 31402691 2020
CUI: C1692886
Disease: Arthritis, Bacterial
Arthritis, Bacterial
0.010 Biomarker group BEFREE Impact of simultaneous neutralization of IL-17A and treatment with recombinant IL-2 on Th17-Treg cell population in S.aureus induced septic arthritis. 31790794 2020
CUI: C2936846
Disease: Scarring alopecia
Scarring alopecia
0.010 Biomarker disease BEFREE IL-17-positive mast cell infiltration in the lesional skin of lichen planopilaris: Possible role of mast cells in inducing inflammation and dermal fibrosis in cicatricial alopecia. 30379356 2020
CUI: C3250443
Disease: MYOTONIC DYSTROPHY 1
MYOTONIC DYSTROPHY 1
0.010 Biomarker disease BEFREE The Th17 signature in DM patients supports the potential use of IL-17 inhibitors in treatment of IIMs. 31292651 2020
Non-radiographic axial spondyloarthritis
0.010 Biomarker disease BEFREE We aimed to evaluate the efficacy and safety of ixekizumab, an IL-17 inhibitor, in non-radiographic axial spondyloarthritis. 31813637 2020
CUI: C0001080
Disease: Achondroplasia
Achondroplasia
0.010 GeneticVariation disease BEFREE We present a patient with ACH resistant to multiple therapies, including the biologic adalimumab, who was successfully treated with an IL-17 inhibitor (ixekizumab). 31184530 2019
CUI: C0001306
Disease: Acute alcoholic liver disease
Acute alcoholic liver disease
0.010 AlteredExpression disease BEFREE These data demonstrate that intermediate monocytes are expanded, functionally activated, induce CD4<sup>+</sup> T cell IL-17 expression, and are enriched in the liver of patients with AH. 31722987 2019
CUI: C0002895
Disease: Anemia, Sickle Cell
Anemia, Sickle Cell
0.010 AlteredExpression disease BEFREE Antibiotic treatment rescued increased intestinal inflammatory cytokine marker genes (Tnfα, IL17, Ifnγ) expression, rescued decreased intestinal barrier marker genes (claudin 3 and claudin 15) expression, and rescued increased serum cytokines (IFNγ, IL27, IL10) in SCD mice. 31209247 2019
CUI: C0003486
Disease: Aortic Aneurysm
Aortic Aneurysm
0.010 AlteredExpression disease BEFREE TLR4, IL-1β, IL-6 and IL-17) were detected in aortic tissues from old control people and AAA cases. 31648011 2019
CUI: C0003509
Disease: Aortitis
Aortitis
0.010 Biomarker disease BEFREE IL-25 enhanced IL-1β and TNF production by IL-25 receptor-expressing dendritic cells and macrophages, respectively, at inflammatory sites of aortae of Il1rn<sup>-/-</sup> mice, contributing to exacerbation of development of IL-1-, TNF- and IL-17A-dependent aortitis in those mice. 31745167 2019
CUI: C0004610
Disease: Bacteremia
Bacteremia
0.010 AlteredExpression disease BEFREE Baseline IL-17A levels were elevated in patients with persistent bacteremia (P < .0001), endovascular (P = .026) and metastatic tissue infections (P = .012). 30165412 2019
CUI: C0004997
Disease: Benign Ovarian Neoplasm
Benign Ovarian Neoplasm
0.010 AlteredExpression disease BEFREE Here, we investigated the distribution patterns of γδ T cells and their main subsets in peripheral blood and tumor tissues among OC patients, benign ovarian tumor (BOT) patients, and age-matched healthy controls (HC) by flow cytometry, as well as the expression levels of IFN-γ and IL-17A secreted from γδ T cells. 31064389 2019
CUI: C0005716
Disease: Blastomycosis
Blastomycosis
0.010 Biomarker disease BEFREE We validated differences in cytokine production between Hmong and European volunteers and formally demonstrated a critical role for IL-6 in the development of adaptive immunity to <i>Blastomyces dermatitidis</i> Our findings suggest that the dysregulation of IL-17 responses underlies a recently reported and poorly understood ethnic health disparity.<b>IMPORTANCE</b> Blastomycosis is a potentially life-threatening infection caused by the fungus <i>Blastomyces dermatitidis</i> As with related fungal diseases, blastomycosis is noted to affect some populations more than others. 31213563 2019